EAN 2017

The neuropathology and genetics of ALS and FTD

Challenges of managing the neuropsychiatric symptoms of Alzheimer’s and vascular dementia

ALS and frontotemporal dementia: on a continuum or part of a spectrum of disorders?

ASL MRI as an early biomarker for Alzheimer’s disease

Investigating physical activity and Alzheimer’s disease

APOE haplotypes, ACE insertion/deletion polymorphism and neuropsychiatric symptoms in Alzheimer’s

Angiotensin receptor blockers on cognitive function in Alzheimer’s disease

A novel biomarker of Alzheimer’s disease progression: LTP-like cortical plasticity

Challenges with comorbidities and dementia

Cerebrospinal fluid (CSF) and imaging biomarkers for the differential diagnosis of dementia

Strategies for the prevention of vascular cognitive impairment

Outcome measures and comorbidities in dementia

Pioglitazone for the treatment of Alzheimer’s disease

Risk factors for developing dementia

Dementia, it’s not only Alzheimer’s disease

Cognitive performance stays stable in chronic kidney disease patients over a 2-year period